These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7755845)

  • 1. Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion.
    Kita T; Wagner GC; Philbert MA; King LA; Lowndes HE
    Mol Chem Neuropathol; 1995 Jan; 24(1):31-41. PubMed ID: 7755845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal formation of 6-hydroxydopamine in mice treated with pargyline, pyrogallol and methamphetamine.
    Liao PC; Kuo YM; Chang YC; Lin C; Cherng CF; Yu L
    J Neural Transm (Vienna); 2003 May; 110(5):487-94. PubMed ID: 12721810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats.
    Marek GJ; Vosmer G; Seiden LS
    Pharmacol Biochem Behav; 1990 May; 36(1):187-90. PubMed ID: 2112259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine-induced modification of dopamine metabolism in cultured striatal astrocytes.
    Kita T; Philbert MA; Wagner GC; Huang J; Lowndes HE
    Pharmacol Toxicol; 1998 Jul; 83(1):36-9. PubMed ID: 9764424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV; Juorio AV; Greenshaw AJ
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
    Fornstedt B; Carlsson A
    Neuropharmacology; 1991 May; 30(5):463-8. PubMed ID: 1907723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
    Garrett MC; Soares-da-Silva P
    Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of striatal dopamine release in rats after acute administration of methamphetamine.
    Tsuchida K; Akiyama K; Sakai K; Ujike H; Li X; Kuroda S
    Pharmacol Biochem Behav; 1996 Mar; 53(3):575-80. PubMed ID: 8866957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between catechol-O-methyltransferase and phenolsulfotransferase in the metabolism of dopamine in the rat brain.
    Buu NT
    J Neurochem; 1985 Nov; 45(5):1612-9. PubMed ID: 3930664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
    Gough B; Pereira FC; Fontes Ribeiro CA; Ali SF; Binienda ZK
    Neurochem Int; 2014 Oct; 76():109-13. PubMed ID: 25049173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
    Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
    Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
    Männistö PT; Tuomainen P
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
    Cadet JL; Brannock C; Krasnova IN; Ladenheim B; McCoy MT; Chou J; Lehrmann E; Wood WH; Becker KG; Wang Y
    PLoS One; 2010 Dec; 5(12):e15643. PubMed ID: 21179447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
    Hefti F; Melamed E
    Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological investigation on the role of dopamine in the rat locus coeruleus.
    Milon H; McRae-Degueurce A
    Neurosci Lett; 1982 Jun; 30(3):297-301. PubMed ID: 6810240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
    Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
    Int J Dev Neurosci; 2000 Oct; 18(6):521-30. PubMed ID: 10884597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study.
    Karoum F; Chrapusta SJ; Egan MF; Wyatt RJ
    J Neurochem; 1993 Oct; 61(4):1369-75. PubMed ID: 8104232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.